Table 2 AMP SCZ Schedule of Clinical Assessments.

From: Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program

Measure

Screening

BL

M1

M2

M3

M4

M5

M6

M7

M8

M9

M10

M11

M12

M18

M24

Conversion

PSYCHS/SOFAS/SCID5-PD-Schizotypal /FIGS/TBI/ medication use

C

                

Health and Medical Conditions Questionnaires

C

C

C

C

 

Demographics

 

C

               

PAS

  

              

Adverse Events

 

C

C

C

C

 

PSYCHS

 

C*

C

  

     

C

C

BPRS

 

C

C

CDSS

 

C

C

  

     

NSI-PR

 

C

C

  

     

OASIS

 

C

C

  

     

CSSRS

 

C

 

C

   

     

PROMIS-SD

 

C

 

C

   

     

ASSIST

 

C

 

   

     

SCID-5-RVs (Psychosis, Mood, Substance Abuse)

 

C

           

 

PGI-S

 

C

C

  

     

GF: Social, GF: Role

 

C

C

  

     

SOFAS

C

C

C

  

     

C

C

PSS

 

C

C

  

     

PD

 

C

               

PDS

 

C

               

PPS

 

C

               

aMinutes for CHR participants

180

300

150

120

120

30

30

150

30

30

30

30

30

180

120

180

180

  1. BL = baseline; =CHR participants; C=Community Control participants (only 5 of the 15 CC at each ProNET site, & 15 of the 100 CC at Melbourne will receive repeat assessments at M2).
  2. PSYCHS Positive Symptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS *skipped at baseline if within 21 days of Screening to reduce participant and rater burden, SOFAS Social and Occupational Functioning Scale, SCID5-PD Structured Clinical Interview for DSM-5 - Personality Disorders, FIGS Family Interview for Genetic Studies, TBI Traumatic Brain Injury, PAS Premorbid Adjustment Scale, BPRS Brief Psychiatric Rating Scale, CDSS Calgary Depression Scale for Schizophrenia, OASIS Overall Anxiety Severity And Impairment Scale, CSSRS Columbia Suicide Severity Rating Scale, PROMIS-SD Patient Reported Outcomes Measurement Information System-Sleep Disturbance, ASSIST Alcohol, Smoking and Substance Involvement Screening Test, SCID-5-RVs Structured Clinical Interview for DSM-5 - Research Version, PGI-S Patient Global Impression of Severity, GF Global Functioning, PSS Perceived Stress Scale, PD Perceived Discrimination, PDS Pubertal Development Scale, PPS Psychosis Polyrisk Score.
  3. aThis presents average time for a CHR participant (CCs take less time) at each clinical assessment completed by a trained and practiced clinical rater.